Monday 7 July 2014

Japan First to Approve Alectinib アレクチニブ 塩酸塩 (AF 802) for ALK+ NSCLC « New Drug Approvals

Japan First to Approve Alectinib アレクチニブ 塩酸塩 (AF 802) for ALK+ NSCLC « New Drug Approvals:



'via Blog this'

No comments:

Post a Comment